Livmarli eases itch for broader pediatric population with Alagille
Livmarli (maralixibat) safely and effectively eases itching caused by Alagille syndrome in children who would have been excluded from the clinical trials that…
Alagille syndrome
New JAG1 mutations seen as likely cause of Alagille in 2 young boys
Researchers have identified two new mutations in JAG1, a gene linked to Alagille syndrome, that each resulted in a unique clinical profile for two…
Recent Posts
- Used in Alagille mice, ASO therapy found to improve liver function
- Gene-editing therapy PBGENE-HBV shows encouraging trial results
- Livdelzi maintains benefits for up to 3 years in PBC: Phase 3 data
- With MASH, managing pain after a major surgery is tricky
- Alagille made us constantly worry about child milestones